Applicant profileSt. Jude Medical, Cardiac Rhythm Management Division
Boston Scientific
Hong Kong MDACSUnited States6 registered devicesNov 26, 2010 – Apr 08, 2021
VerifiedMDD (Medical Device Division) · MDACS registry
6
Total devices
1
Risk classes
2010
First registration
2021
Most recent
Applicant overview
- Applicant (EN)
- St. Jude Medical, Cardiac Rhythm Management Division
- Applicant (ZH)
- Boston Scientific
- Country
- United States
- Address
- 15900 Valley View Court, Sylmar, CA 91342, USA
美国
15900山谷景观法院,西尔马,CA 91342,美国
Timeline
- First registration
- Nov 26, 2010
- Most recent
- Apr 08, 2021
Regulatory footprint
Search St. Jude Medical, Cardiac Rhythm Management Division across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRisk class breakdown
IV6
Recent MDACS registrations
Latest 15 devices linked to this applicant
Leads, Implantable Cardiac Pacemaker, Endocardial
导联线、植入式心脏起搏器、心内膜
Apr 08, 2021
- Risk class
- IV
- Authorised rep
- Abbott Medical (Hong Kong) Limited美国雅培医疗用品(香港)有限公司
Leads, Implantable Cardiac Pacemaker, Endocardial
导联线、植入式心脏起搏器、心内膜
Apr 08, 2021
- Risk class
- IV
- Authorised rep
- Abbott Medical (Hong Kong) Limited美国雅培医疗用品(香港)有限公司
Leads, Implantable Defibrillator/Pacemaker
导线,植入式除颤器/起搏器
Sep 18, 2018
- Risk class
- IV
- Authorised rep
- Abbott Medical (Hong Kong) Limited美国雅培医疗用品(香港)有限公司
Leads, Implantable Cardiac Pacemaker, Endocardial
导联线、植入式心脏起搏器、心内膜
Apr 08, 2016
- Risk class
- IV
- Authorised rep
- Abbott Medical (Hong Kong) Limited美国雅培医疗用品(香港)有限公司
Pacemakers, Cardiac
心脏起搏器
Aug 14, 2012
- Risk class
- IV
- Authorised rep
- Abbott Medical (Hong Kong) Limited美国雅培医疗用品(香港)有限公司
Leads, Pacemaker, Implantable, Endocardial
导线、起搏器、植入式、心内膜
Nov 26, 2010
- Risk class
- IV
- Authorised rep
- Abbott Medical (Hong Kong) Limited美国雅培医疗用品(香港)有限公司
About this profile
St. Jude Medical, Cardiac Rhythm Management Division is associated with 6 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.